TY - JOUR A1 - Neumann, Martin A1 - Heesch, Sandra A1 - Gökbuget, Nicola A1 - Schwartz, Stefan A1 - Schlee, Cornelia A1 - Benlasfer, Ouidad A1 - Farhadi-Sartangi, Nasrin A1 - Thibaut, Julia A1 - Burmeister, Thomas A1 - Hoelzer, Dieter A1 - Hofmann, Wolf-Karsten A1 - Thiel, Eckhard A1 - Baldus, Claudia T1 - Clinical and molecular characterization of early T-cell precursor leukemia : a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations T2 - Blood cancer journal N2 - A subgroup of pediatric acute T-lymphoblastic leukemia (T-ALL) was characterized by a gene expression profile comparable to that of early T-cell precursors (ETPs) with a highly unfavorable outcome. We have investigated clinical and molecular characteristics of the ETP-ALL subgroup in adult T-ALL. As ETP-ALL represents a subgroup of early T-ALL we particularly focused on this cohort and identified 178 adult patients enrolled in the German Acute Lymphoblastic Leukemia Multicenter studies (05/93–07/03). Of these, 32% (57/178) were classified as ETP-ALL based on their characteristic immunophenotype. The outcome of adults with ETP-ALL was poor with an overall survival of only 35% at 10 years, comparable to the inferior outcome of early T-ALL with 38%. The molecular characterization of adult ETP-ALL revealed distinct alterations with overexpression of stem cell-related genes (BAALC, IGFBP7, MN1, WT1). Interestingly, we found a low rate of NOTCH1 mutations and no FBXW7 mutations in adult ETP-ALL. In contrast, FLT3 mutations, rare in the overall cohort of T-ALL, were very frequent and nearly exclusively found in ETP-ALL characterized by a specific immunophenotype. These molecular characteristics provide biologic insights and implications with respect to innovative treatment strategies (for example, tyrosine kinase inhibitors) for this high-risk subgroup of adult ETP-ALL. KW - acute lymphoblastic leukemia KW - ETP-ALL KW - T-ALL KW - molecular characteristics KW - FLT3 KW - NOTCH1 Y1 - 2012 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/24462 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-244627 SN - 2044-5385 VL - 2 IS - e55 PB - Nature Publishing Group CY - London [u.a.] ER -